healingMolecular Weight: 1257.4Reviewed: 2026-03-26

ARA-290

Cibinetide

A peptide derived from erythropoietin (EPO) that targets inflammation and nerve pain.

Quick Answer

ARA-290 is a niche but valuable opportunity page because users search with very specific dosage and context questions that few sites answer well.

Shop ARA-290

Mechanism

Selective agonist of the innate repair receptor (IRR) that reduces inflammation and promotes tissue repair.

Half-Life

Short

Administration

Subcutaneous

Technical Protocol

ARA-290 Guide

ARA-290 is primarily researched for small fiber neuropathy and inflammatory conditions.

Answer-First Research Snapshot

Evidence

The opportunity is less about volume and more about serving a motivated audience with a better, safer explanation than low-quality forums.

Dosage Context

Protocol-style questions should be answered, but always with clear boundaries around evidence quality and intended research framing.

Status

The page should lead with research status and uncertainty rather than imply settled clinical relevance.

Answer specific protocol queries while keeping conservative framing.

Tie ARA-290 to safety and regulatory content quickly.

Use adjacent peptide links to keep users exploring the site.

Peer-Reviewed Citations

ARA 290, a peptide derived from erythropoietin, for the treatment of sarcoidosis

Dahan A, et al. • Mol Med (2013)

Access Research

Frequently Asked Questions

Why is ARA-290 an opportunity despite low volume?

Because the queries are highly specific and usually come from users with strong intent, making the page valuable if it answers clearly and responsibly.

How should ARA-290 be stored?

Store at 2-8°C, protect from light

Continue the Research Path

Source ARA-290 for Your Research

Third-party tested, EU-shipped, certificate of analysis included. High-purity ARA-290 available from our verified research partner.

Shop ARA-290

Related Healing Peptides